Novo Nordisk likely to offer stem cell therapy for diabetes treatment

Danish drugmaker Novo Nordisk A/S is known to be the world leader in diabetes. Now in their hunt for diabetes drug, the company is trying to take the help of stem cell research.In this effort, they have launched a new collaboration to develop a treatment for type 1 diabetes by programing stem cells to turn into insulin-producing cells.

Full article »

R1583 Type 2 Diabetes (NIDDM) Drug Gets Strong Rating

A drug having code number R 1583, a Swiss company’s product, is going to mark a significant improvement in the history of medical Diabetes.

Full article »

Protected by Comment Guard Pro